🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Intravitreal injections of pegaptanib every 4 weeks will be efficacious in ...
Status
Completed
Location
Valley Retina Institute,PA
Start Date
2009-04
Trial ID
NCT01486238
Treatments Being Tested
To evaluate the safety and determine the efficacy of PRP monotherapy or com...
Status
Completed
Location
Center for Clinical Trials - Aibili
Start Date
2010-03
Trial ID
NCT01281098
Treatments Being Tested
The purpose of this study is to assess the efficacy of pegaptanib (Macugen®...
Status
Unknown
Location
Department of Ophthalmology, Ludwigshafen hospital
Start Date
2008-11
Trial ID
NCT00788177
Treatments Being Tested
The purpose of the study is to test whether Macugen injected into the eye i...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2005-09
Trial ID
NCT00605280
Treatments Being Tested
To evaluate the safety and efficacy of the combination treatments in wet ag...
Status
Completed
Location
Novartis Investigational Site
Start Date
2005-09
Trial ID
NCT00242580
Treatments Being Tested
Intravitreal injections of pegaptanib will induce the regression of Prolife...
Status
Unknown
Location
Valley Retina Insitute, PA
Start Date
2007-11
Trial ID
NCT01486771
Treatments Being Tested
Long-term observational study to assess the safety, efficacy and quality of...
Status
Completed
Location
Multiple Locations
Start Date
2006-08
Trial ID
NCT01245387
Treatments Being Tested